Journal of neurologyHumansMaleAgedFemaleImmune Checkpoint Inhibitors
Neurological immune-related adverse events of immune checkpoint inhibitors: clinical and hematological risk factors.
Luca Marsili, Jesus Abanto, Samuel B Marcucci, Kevin R Duque, Martina Chirra, Joseph LaPorta, Hannah VanDusen, Neha Paruchuri, Ayesha Shaik, Trisha Wise-Draper, Alberto J Espay, Alberto Vogrig
Published: 202510.1007/s00415-025-13540-z
Abstract
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but can induce neurological immune-related adverse events (n-irAEs). OBJECTIVE: We aimed at evaluating the occurrence and characteristics of n-irAEs in cancer patie…
Preview only. Read the full abstract at the source